|
Theranostic Nanoparticles for Activation of Tumor-Specific Immune Responses
Application
Tumor-targeted nanoparticles for the delivery of anti-PD-L1 peptides for treatment of cancers.
Key Benefits
Nanoparticles loaded with a variety of drugs and/or peptides for prolonged therapeutic delivery to tumor sites.
Targeted delivery to tumor sites can reduce level of dosing and side effects.
Market Summary
PD-L1 is expressed...
Published: 4/8/2024
Contributor(s): Lily Yang, Erica Bozeman
|